申请人:Okubo Taketoshi
公开号:US20090291940A1
公开(公告)日:2009-11-26
Disclosed is an aminopyrrolidine compound represented by the formula [I] or a pharmaceutically acceptable salt thereof. The compound or the salt is useful as a prophylactic/therapeutic agent for mode disorder such as depression, anxiety disorder, anorexia, cachexia, pain and drug dependence, whose action relies on the MC
4
receptor antagonistic effect.
本发明公开了一种氨基吡咯烷化合物,其化学式为[I],或其药学上可接受的盐。该化合物或其盐可用作预防/治疗药物,针对情绪障碍,如抑郁症、焦虑症、厌食症、消瘦症、疼痛和药物依赖等,其作用依赖于MC4受体拮抗作用。